Graft Reinforcement for Posterior Nasal Nerve Neurectomy in Allergic Rhinitis Surgeries
NCT05880134 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2024-09-19
Summary
Rhinitis is defined clinically as having two or more symptoms of anterior or posterior rhinorrhea, sneezing, nasal blockage and/or itching of the nose during two or more consecutive days for more than 1 h on most days.
Allergic rhinitis is diagnosed when these symptoms are caused by allergen exposure leading to an IgE mediated reaction. The inflammatory mediators produced because of this IgE mediated reaction causes the classical symptoms of allergic rhinitis.
Nerve irritation causes sneezing and itching, the loss of mucosal integrity causes rhinorrhea, and the vascular engorgement leads to nasal blockage.
Based on the nasal symptoms the prevalence of allergic rhinitis in the Indian population is 20-30%.
Allergic rhinitis significantly affects the quality of life, it contributes to missed or unproductive time at school or work, disturbed sleep pattern and daytime somnolence.
The most popular and widely accepted treatment strategy for allergic rhinitis is pharmacotherapy, this includes antihistamines, leukotriene receptor antagonist and intranasal corticosteroids. These medical modalities are symptomatically effective in mild cases, with temporary relief and addressable adverse effects. Prolonged treatment with allergy immunotherapy causes a sustainable financial burden while remaining inaccessible at smaller towns.
Rhinorrhea is a frequent symptom reported amongst patients with allergic and vasomotor rhinitis. Most of these patients usually respond well to medical treatment.
Indications for surgical treatment are warranted only when medical treatment fails, or a patient wants a permanent solution.
In 1961, Golding-Wood first described vidian neurectomy for the treatment of allergic and vasomotor rhinitis. There was a high incidence of post-operative complications, such as disturbed lacrimal secretion and numbness of the cheek and gums. In 2007, Kikawada reported an endoscopic technique involving resection of the posterior nasal nerve near the sphenopalatine artery. With this technique, any intra-operative bleeding can be controlled under direct vision. In 2008, Ikeda et al. described submucosal reduction of the inferior turbinate and resection of the posterior nasal nerve. This resulted in significant improvements in nasal symptoms for patients with resistant chronic rhinitis (rhinorrhea).
The posterior nasal nerve is a peripheral branch of the sphenopalatine ganglion. It enters the nasal cavity through a separate foramen, 4-5 mm below the sphenopalatine foramen, after bifurcation of the nerve into the lacrimal nerve. The posterior superior nasal nerves innervate the superior and middle turbinates, and the superior and middle meatus.
Other parasympathetic nerve fibres of the nose branch off and joins the greater palatine nerve and enters the nasal cavity through the canaliculi in the perpendicular plate of the palatine bone as the posterior inferior nasal nerves. These nerves innervate the inferior turbinate and the inferior meatus.
Conditions
- Neurectomy
Interventions
- PROCEDURE
-
conventional posterior nerve neurectomy
A vertical incision is made behind the posterior fontanelle. The posterior end of the posterior fontanelle is identified by palpation with an elevator. . The mucoperiosteum is raised gently using a Cottle elevator or a suction freer elevator, after making the initial incision. Care must be taken not to injure the sphenopalatine vessel during flap elevation. The peripheral part of the posterior nasal nerve can usually be identified just behind the incision, about 4-5 mm inferior to the sphenopalatine artery or crista ethmoidalis. I After identifying the nerve fibres, it is cauterised using monopolar suction cautery and cut using microscissors. It is essential to carry out this procedure on both sides for effective results.
- PROCEDURE
-
cartilage graft reinforcement after posterior nerve neurectomy
A vertical incision is made behind the posterior fontanelle. The posterior end of the posterior fontanelle is identified by palpation with an elevator. . The mucoperiosteum is raised gently using a Cottle elevator or a suction freer elevator, after making the initial incision. Care must be taken not to injure the sphenopalatine vessel during flap elevation. The peripheral part of the posterior nasal nerve can usually be identified just behind the incision, about 4-5 mm inferior to the sphenopalatine artery or crista ethmoidalis. I After identifying the nerve fibres, it is cauterised using monopolar suction cautery and cut using microscissors. It is essential to carry out this procedure on both sides for effective results. then harvest cartilage from nasal septum and refashion it around sphenopalatine bundle to prevent nerve re-innervation The mucoperiosteal flaps are repositioned . No nasal packing is required. Patients are discharged on the same day
Sponsors & Collaborators
-
Kafrelsheikh University
lead OTHER
Principal Investigators
-
Mohammad Aouf · kafrelsheikh U
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-12
- Primary Completion
- 2023-05-30
- Completion
- 2023-11-30
Countries
- Egypt
Study Locations
More Related Trials
-
Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients
NCT06858423 ·Status: COMPLETED ·Phase: PHASE4
-
International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis
NCT02041624 ·Status: TERMINATED
-
A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.
NCT06028490 ·Status: UNKNOWN ·Phase: PHASE2
-
Acupuncture for Seasonal Allergic Rhinitis
NCT00610584 ·Status: COMPLETED ·Phase: NA
-
Study Of Allergic Rhinitis In Patients Who Also Have Asthma
NCT00296491 ·Status: COMPLETED ·Phase: PHASE4
-
Pilates Training in Patients With Allergic Rhinitis
NCT05693883 ·Status: COMPLETED ·Phase: NA
-
A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine
NCT01103050 ·Status: COMPLETED ·Phase: PHASE2
-
Role of the Central Nervous System in Allergic Rhinitis
NCT01777464 ·Status: TERMINATED ·Phase: NA
-
Nasya in Allergic Rhinitis
NCT01503957 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
NCT00461721 ·Status: COMPLETED
-
A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults
NCT00116818 ·Status: COMPLETED ·Phase: PHASE3
-
Study Of Perennial Allergic Rhinitis
NCT00358475 ·Status: COMPLETED ·Phase: PHASE3
-
PILOT STUDY OF THE EFFICACY AND SAFETY OF WF10 IN SUBJECTS SUFFERING FROM PERSISTENT ALLERGIC RHINITIS
NCT01586468 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis
NCT00550875 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
NCT01240889 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Levocetirizine and Fexofenadine
NCT01586091 ·Status: COMPLETED ·Phase: PHASE4
-
Subjects With Clinical Diagnosis of Allergic Rhinitis Were Randomly Divided Into 2 Groups, With Patients in One Group Given One Treatment Session of Red Light Rhinophototherapy, Followed by Medical Treatment. Those in the Second Group Were Treated With Medical Treatment Only.
NCT03752645 ·Status: COMPLETED ·Phase: NA
-
Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma
NCT01634958 ·Status: COMPLETED ·Phase: PHASE2
-
Special Drug Use Investigation for ALLERMIST (Long Term)
NCT01420822 ·Status: COMPLETED
-
Washed Microbiota Transplantation for Rhinitis
NCT06350448 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Leukotriene D4 Nasal Provocation Test in Allergic Rhinitis
NCT01963741 ·Status: COMPLETED ·Phase: NA
-
Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
NCT02000648 ·Status: COMPLETED
-
Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts
NCT02506998 ·Status: COMPLETED ·Phase: PHASE2
-
Allergenic Extract Standardized Cat Hair AP in an Allergic Rhinitis Model.
NCT06828484 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
AUTO-ACUSAR - Effects of Acupuncture on the Autonomic Nervous System in Seasonal Allergic Rhinitis Patients
NCT01271595 ·Status: COMPLETED ·Phase: NA